Suchergebnisse

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer von Sebastian, Martin (VerfasserIn) , Thomas, Michael (VerfasserIn) ,

• Verlag, Pay-per-use, Volltext

Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljub... von Aptsiauri, Natalia (VerfasserIn) , Umansky, Viktor (VerfasserIn) ,

• Verlag, Volltext